Madrigal Pharmaceuticals Insider Trades

MDGL

Track insider trading activity from Madrigal Pharmaceuticals executives and directors. See which insiders are buying and selling MDGL stock.

Trades Last 12 Months

MDGL Price

All Insider Trades for Madrigal Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sibold William John President And CEO
Holding Value $87.5M 202,907 shares
Last Trade
Sep 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.83M 5,221 shares
$542.38
$431.16
Kelley Shannon T General Counsel
Holding Value $4.95M 11,474 shares
Last Trade
Aug 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$342k 664 shares
$514.97
$431.16
Reed John C Director
Holding Value $465k 1,078 shares
Last Trade
Aug 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$876k 1,725 shares
$507.56
$431.16
Holding Value $840M 1,948,876 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.67M 3,348 shares
$499.76
$431.16
Taub Rebecca Director
Holding Value $195M 452,667 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$610k 1,220 shares
$499.76
$431.16
Holding Value $591k 1,371 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$542k 1,085 shares
$499.76
$431.16
Levy Richard S Director
Holding Value $9.69M 22,469 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$610k 1,220 shares
$499.76
$431.16
Holding Value $669k 1,551 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$610k 1,220 shares
$499.76
$431.16
Daly James M Director
Holding Value $1.33M 3,081 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$610k 1,220 shares
$499.76
$431.16
Soergel David Chief Medical Officer
Holding Value $4.33M 10,033 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$517k 1,042 shares
$495.74
$431.16
Dier Mardi EVP And CFO
Holding Value $5.96M 13,826 shares
Last Trade
Mar 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$854k 1,982 shares
$430.88
$431.16
Huntsman Carole Chief Commercial Officer
Holding Value $5.47M 12,692 shares
Last Trade
Mar 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$181k 419 shares
$431.94
$431.16
Thakkar Rita Chief Accounting Officer
Holding Value $1.03M 2,398 shares
Last Trade
Jan 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.09M 4,224 shares
$495.88
$431.16
Friedman Paul A Director
Holding Value $81.8M 189,804 shares
Last Trade
Jan 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$42.6k 80 shares
$532.50
$431.16
Bate Kenneth Director
Holding Value $3.84M 8,896 shares
Last Trade
Nov 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$936k 1,931 shares
$484.78
$431.16
Holding Value $840M 1,947,968 shares
Last Trade
Aug 20, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.1M 59,901 shares
$385.16
$431.16
Holding Value $473k 1,097 shares
Last Trade
Jun 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$105k 366 shares
$285.73
$431.16
Craves Fred B Director
Holding Value $153M 355,867 shares
Last Trade
Mar 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.52M 7,742 shares
$325.25
$431.16
Waltermire Robert E. Senior Vp, Chief Pharma Dev.
Holding Value $7.3M 16,941 shares
Last Trade
Mar 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.82M 14,113 shares
$341.33
$431.16
Lynch Brian Joseph SVP And General Counsel
Holding Value $7.63M 17,691 shares
Last Trade
Jan 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.92M 12,761 shares
$229.00
$431.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up